AP NEWS

Superdisintegrants Market by Product, Formulation, Therapeutic Area - Global Forecast to 2023 - ResearchAndMarkets.com

September 7, 2018

DUBLIN--(BUSINESS WIRE)--Sep 7, 2018--The “Superdisintegrants Market by Product, Formulation, Therapeutic Area - Global Forecast to 2023” report has been added to ResearchAndMarkets.com’s offering.

The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%.

The increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry are the factors driving the market for superdisintegrants.

The shifting focus of pharmaceutical manufacturing to emerging markets and the growth of the overall pharmaceutical sector in these markets present significant opportunities for the superdisintegrants market growth. However, safety and quality concerns are expected to challenge the growth of the superdisintegrants market to a certain extent during the forecast period.

By type, the superdisintegrants market is segmented into natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. The synthetic superdisintegrants segment is further subsegmented into modified starch, cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, ion exchange resins, and calcium silicates.

The synthetic superdisintegrants segment is expected to register the highest CAGR during the forecast period. This growth can be attributed to the widespread use of these superdisintegrants in various oral drug formulations, especially in orally disintegrating tablets.

By formulation, the superdisintegrants market is segmented into tablets and capsules. The tablets segment is expected to witness the highest CAGR owing to the widespread use of orally disintegrating tablets (ODT) and fast-disintegrating tablets among healthcare providers and patients driven by the advantages such as increasing drug bioavailability, better pregastric absorption, ease of swallowing in patients with dysphagia, ease of administration, and improved shelf life.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Regulatory Analysis

7 Superdisintegrants Market, By Type

8 Superdisintegrants Market, By Formulation

9 Superdisintegrants Market, By Therapeutic Area

10 Superdisintegrants Market, By Region

11 Competitive Landscape

12 Company Profiles

Ashland Inc. BASF SE DowDuPont JRS Pharma DFE Pharma Roquette Asahi Kasei Corporation Merck KGaA Corel Pharma Chem Avantor Performance Materials, LLC For more information about this report visit https://www.researchandmarkets.com/research/dwk4fz/superdisintegrants?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180907005156/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Pharmaceutical Intermediates

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/07/2018 06:54 AM/DISC: 09/07/2018 06:54 AM

http://www.businesswire.com/news/home/20180907005156/en

AP RADIO
Update hourly